New-onset Ankylosing Spondylitis after COVID-19 mRNA Vaccine: A Case Report

Tuğba Özüdoğru Çelik

doi:10.46332/aemj.1757850

Enriched recordOpen access

New-onset Ankylosing Spondylitis after COVID-19 mRNA Vaccine: A Case Report

Tuğba Özüdoğru Çelik

Ahi Evran Medical Journal2026doi:10.46332/aemj.1757850

Citation graph

Abstract

Autoimmune/autoinflammatory diseases, including rheumatic diseases, may occur and/or flare up after COVID-19 vaccines, due to the molecular similarities between viral antigens and antigenic structures in the human body. In this case, the aim is to present the diagnostic process of Ankylosing Spondylitis and the initiation of treatment of a 32-year-old young male patient whose complaints started after the Pfizer-BioNTech COVID-19 vaccine.

Authors

Tuğba Özüdoğru Çelik#1

Institutions

No ROR-resolved institution is linked to this work yet.

Provenance

crossref

Confidence 100%

unpaywall

Confidence 95%

doaj

Confidence 92%

datacite

Confidence 0%

Referenced works

View all references →

No local reference links have been materialized yet.

Cited by

View all cited-by records →

No local citing links have been materialized yet.

External reference records

10.1136/annrheumdis-2021-221490

10.1016/j.autrev.2021.102792

10.1097/bor.0000000000000776

10.1016/j.intimp.2022.109061

Unresolved referenced work

Kept as external metadata until matched

10.1016/j.clim.2021.108665

10.1111/cts.12805

10.1136/annrheumdis-2020-218009

10.1111/imm.13443

10.1007/s00296-021-04998-x

Unresolved referenced work

Kept as external metadata until matched

10.1093/qjmed/hcab043

New-onset Ankylosing Spondylitis after COVID-19 mRNA Vaccine: A Case Report

Referenced works

Cited by

External reference records

Additional external references